Patrice Wendling

News

Triple Therapy With Vorapaxar Fails in ACS

Author:: Patrice Wendling

Publish date: November 14, 2011

Major Finding: The primary end point occurred in 18.5% of patients treated with vorapaxar and 19.9% with placebo (P = .072; hazard ratio, 0.92). D...

News

ISAR-REACT 4 Trial Backs Bivalirudin for NSTEMI

Author:: Patrice Wendling

Publish date: November 13, 2011

Major Finding: The primary composite end point occurred in 10.9% of patients treated with abciximab plus heparin and in 11% treated with bivalirud...

News

Most Smokers Want to Quit; Few Get Help

Author:: Patrice Wendling

Publish date: November 10, 2011

News

ASCO: Cancer Research Must Change Course in 'Molecular Era'

Author:: Patrice Wendling

Publish date: November 4, 2011

News

BP Readings Add Nothing to Pulse Oximetry Screening

Author:: Patrice Wendling

Publish date: November 1, 2011

Major Finding: In all, 84% of infants who failed the initial screening, failed based on blood pressure measurements alone.Data Source: Retrospecti...

News

HHS Joins Call For Newborn Heart Disease Screening

Author:: Patrice Wendling

Publish date: October 31, 2011

News

Cyclic Parenteral Nutrition Feasible in VLBW Infants

Author:: Patrice Wendling

Publish date: October 20, 2011

Major Finding: The incidence of cholestasis was 24% with continuous parenteral nutrition vs.

News

Hysterectomy No Boon in Early-Stage Ovarian Cancer

Author:: Patrice Wendling

Publish date: October 18, 2011

Major Finding: Three-year event-free survival was 72% with hysterectomy vs. 89% without (P = .17).Data Source: Phase III GYNECO 02 Study in 61 wom...

News

Denosumab Delays Bone Metastases in Castrate-Resistant Prostate Cancer

Author:: Patrice Wendling

Publish date: October 13, 2011

Major Finding: Median bone metastasis-free survival was increased from 25.2 months with placebo to 29.5 months with denosumab (hazard ratio, 0.85;...

News

Celecoxib Gives No Boost to Hormone Therapy in Prostate Cancer

Author:: Patrice Wendling

Publish date: October 12, 2011

Major Finding: The 305 failure-free survival events were largely PSA failures in 78% of both groups and new metastases in 16% of both groups,Data ...

News

Laparoscopic Surgery Safe for Radical Rectal Cancer Resection

Author:: Patrice Wendling

Publish date: October 11, 2011

Major Finding: The circumferential resection margin was 1.3 cm after laparoscopic and open surgery (P = .16).Data Source: A noninferiority randomi...

News

Ivabradine Reverses Left Ventricular Remodeling in Heart Failure

Author:: Patrice Wendling

Publish date: October 6, 2011

Major Finding: At 8 months, left ventricular end-systolic volume index was reduced 7 mL/m2 in the ivabradine group vs.

News

Vismodegib Shrinks Advanced Basal Cell Carcinoma

Author:: Patrice Wendling

Publish date: October 6, 2011

Major Finding: The overall response rate by independent review was 43% for locally advanced BCC (P less than .0001) and 30% for metastatic BCC (P ...

News

Novel Drug TAS-102 Makes Headway in Refractory Colorectal Cancer

Author:: Patrice Wendling

Publish date: October 4, 2011

Major Finding: Median overall survival was 9 months for TAS-102 plus best supportive care vs.

News

Pregnancy Outcomes Not Marred by H1N1 Flu

Author:: Patrice Wendling

Publish date: October 1, 2011